Prescribing information For Healthcare Professionals Only

Concerta® XL Prolonged Release Tablets

ACTIVE INGREDIENT(s): methylphenidate hydrochloride

Prescribing information

Daktacort®

2% / 1% w/w
Cream and Ointment

ACTIVE INGREDIENT(s): Miconazole nitrate 2% w/w and hydrocortisone 1% w/w

Prescribing information

Darzalex®

20 mg/ml Concentrate
for Solution for Infusion and 1,800 mg Solution for Injection.

ACTIVE INGREDIENT(s): Daratumumab

Prescribing information

Durogesic® Dtrans®

12/25/50/75/100 mcg/hr
Transdermal Patch

ACTIVE INGREDIENT(s): fentanyl

Prescribing information

ERLEADA®

60 mg film-coated tablets

ACTIVE INGREDIENT(s): Apalutamide

Prescribing information

EVRA®

203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch

ACTIVE INGREDIENT(s): norelgestromin and ethinyl estradiol

Prescribing information

HALDOL®

2 mg/ml oral solution

ACTIVE INGREDIENT(s): Haloperidol

Prescribing information

HALDOL® decanoate

50 mg/ml and 100 mg/ml solution for injection

ACTIVE INGREDIENT(s): Haloperidol decanoate

Prescribing information

IMBRUVICA®

140mg, 280mg, 420mg and 560mg Film-coated Tablets

ACTIVE INGREDIENT(s): ibrutinib

Prescribing information

INVEGA®

3mg, 6 mg and 9 mg prolonged release tablets

ACTIVE INGREDIENT(s): paliperidone

Prescribing information

Opsumit®

10mg film-coated tablets

ACTIVE INGREDIENT(s): Macitentan

Prescribing information

RISPERDAL® CONSTA®

25mg, 37.5mg and 50mg injection

ACTIVE INGREDIENT(s): risperidone

Prescribing information

RISPERDAL® Film-Coated Tablets, and Oral Solution

Tablets, Oral Solution and Risperdal® Quicklet® Orodispersible Tablets

ACTIVE INGREDIENT(s): risperidone

Prescribing information

SPRAVATO®

28 mg nasal spray, solution

ACTIVE INGREDIENT(s): Esketamine hydrochloride

Prescribing information

STELARA®

45 mg and 90 mg solution for injection and 130 mg concentrate for solution for infusion

ACTIVE INGREDIENT(s): ustekinumab

Prescribing information

Tracleer®

62.5 & 125 mg film-coated tablets

ACTIVE INGREDIENT(s): Bosentan

Prescribing information

Tremfya®

100 mg solution for injection in pre-filled pen 

ACTIVE INGREDIENT(s): Guselkumab

Prescribing information

TREVICTA®

175 mg, 263 mg, 350 mg & 525 mg prolonged release suspension for injection

ACTIVE INGREDIENT(s): paliperidone

Prescribing information

UPTRAVI®

200-1600 µg film-coated tablets

ACTIVE INGREDIENT(s): Selexipag

Prescribing information

VELCADE®

3.5 mg powder for solution for injection

ACTIVE INGREDIENT(s): bortezomib

Prescribing information

VELETRI®

0.5mg and 1.5mg, powder for solution for infusion

ACTIVE INGREDIENT(s): Epoprostenol

Prescribing information

XEPLION®

50 mg, 75 mg, 100 mg & 150 mg prolonged release suspension for injection

ACTIVE INGREDIENT(s): paliperidone

Prescribing information

ZYTIGA®

500 mg film-coated tablets

ACTIVE INGREDIENT(s): abiraterone acetate

Prescribing information

Darzalex®

20 mg/ml Concentrate
for Solution for Infusion and 1,800 mg Solution for Injection.

in combination with VELCADE®

3.5 mg powder for solution for injection

in combination with

ACTIVE INGREDIENT(s): Daratumumab and bortezomib and

Prescribing information
You are now leaving a Janssen website

This link will take you to a website where our Privacy Policy does not apply.

Click OK to continue.